deflazacort 6 MG Oral Tablet [Kymbee]
deflazacort
RxCUI: 2725491
What the CMS Formulary Data Shows for deflazacort 6 MG Oral Tablet [Kymbee]
Per the CMS 2026 Part D formulary file, deflazacort 6 MG Oral Tablet [Kymbee] (RxNorm concept RXCUI 2725491, generic name deflazacort) appears on 14 distinct formulary files spanning 688 Medicare Part D plan offerings - 13.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to deflazacort 6 MG Oral Tablet [Kymbee] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 35.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 99 Part D beneficiaries filled deflazacort 6 MG Oral Tablet [Kymbee] in 2023, with total plan-and-beneficiary spending of $15,369,330 and an average per-beneficiary annual cost of $155,245.76. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry deflazacort 6 MG Oral Tablet [Kymbee] today.
Coverage Details
- Formularies covering
- 14
- Plans covering
- 688
- Coverage rate
- 13.6%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 35.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 99
- Total spending
- $15,369,330
- Avg per beneficiary
- $155,245.76
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering deflazacort 6 MG Oral Tablet [Kymbee]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is deflazacort 6 MG Oral Tablet [Kymbee] covered by Medicare Part D?
Yes, deflazacort 6 MG Oral Tablet [Kymbee] is covered by 688 Medicare Part D plans (13.6% of all Part D formularies).
What tier is deflazacort 6 MG Oral Tablet [Kymbee] on Medicare Part D plans?
deflazacort 6 MG Oral Tablet [Kymbee] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does deflazacort 6 MG Oral Tablet [Kymbee] require prior authorization?
100% of Part D formularies require prior authorization for deflazacort 6 MG Oral Tablet [Kymbee]. Step therapy: 0%. Quantity limits: 35.7%.
How much does Medicare spend on deflazacort 6 MG Oral Tablet [Kymbee]?
In 2023, total Medicare Part D spending on deflazacort 6 MG Oral Tablet [Kymbee] was $15,369,330, covering 99 beneficiaries. The average spend per beneficiary was $155,245.76.
Read our methodology - how this data is sourced, computed, and verified.